To date, results from structural and functional assays by several multicenter trials suggested that IDH1 R132, which resides at the active site of enzyme substrate affinity, promotes oncogenesis in both glioma and AML [9,11,20,33]. The gene discussed is IDH1; the disease is acute myeloid leukemia.